Noom Med review (2026): microdose pricing, pros and cons
As of October 15, 2026, the only Noom Med GLP-1 price we could rank is its microdose compounded semaglutide: $79 for an initial three-week subscription with four weeks of medication, then $179 a month plus tax on 12-week subscriptions, with medication, clinical visits and program access included.
Noom’s standard compounded programs showed no rankable price, and a microdose is a lower-dose treatment, not a discount on the doses studied in trials.
Verdict
Noom Med pairs medication with Noom’s behaviour-change app and coaching. Its one clearly priced GLP-1 product is the Microdose GLP-1Rx program: $79 buys an initial three-week subscription with four weeks of compounded semaglutide, then it is $179 a month plus tax on 12-week subscriptions. Noom says this includes medication, clinical visits and program access, and you can cancel any time. The pricing applies to new accounts from July 27, 2026.
Be clear about what a microdose is. It sits below the doses tested in the semaglutide weight-loss trials, so trial results do not describe it, and it is not the same treatment at a lower price. For a standard-dose comparison on the same date, NexLife’s compounded semaglutide was $139 month to month and $119 a month on a 12-month plan, and Eden Health charged $99 a month. Noom’s own page says its compounded semaglutide is “produced in an FDA-registered facility but has not been reviewed by the FDA”.
Noom’s hub pages showed only general “starting at” figures without a plan, so we could not price its standard compounded semaglutide or tirzepatide. This site has not yet scored Noom Med on methodology v4.1 (v4.1 score pending).
Snapshot
| Field | What the provider’s page says | Source · read date | Status |
|---|---|---|---|
| Microdose semaglutide, start | $79: 3-week subscription, 4 weeks of medication | noom.com/med/glp1-microdose · October 15, 2026 | Verified |
| Microdose semaglutide, ongoing | $179 a month plus tax, 12-week subscriptions | noom.com/med/glp1-microdose · October 15, 2026 | Verified |
| Included | Medication, clinical visits, program access | noom.com · October 15, 2026 | Verified |
| Cancellation | “Cancel anytime” | noom.com · Sept 17, 2026 | Reported — pending verification |
| Standard compounded semaglutide / tirzepatide | No rankable price | noom.com/med · October 15, 2026 | No published price |
| Pricing effective date | New accounts from July 27, 2026 | noom.com · Sept 17, 2026 | Reported — pending verification |
| Pharmacy | “FDA-registered facility”, not named | noom.com · October 15, 2026 | Not disclosed |
Pricing, October 15, 2026
Noom quotes $179 “per month” on a 12-week subscription. How the 12 weeks are charged (monthly or up front) is not spelled out on the page, so ask before you subscribe.
| Program | Price | Basis | Source · read date |
|---|---|---|---|
| Microdose semaglutide, first period | $79 plus tax | 3-week subscription, 4 weeks of medication | noom.com · October 15, 2026 |
| Microdose semaglutide, after | $179 a month plus tax | 12-week subscriptions | noom.com · October 15, 2026 |
| Standard compounded semaglutide | Not printed | — | noom.com/med · October 15, 2026 |
| Standard compounded tirzepatide | Not printed | — | noom.com/med · October 15, 2026 |
What changed since our July 2026 review
The July 2026 figures below are kept only so you can see what moved. None of them is a current price.
| Item | July 2026 (superseded) | October 15, 2026 |
|---|---|---|
| Semaglutide, dose-capped plan | $199 (capped at 0.6 mg) | Not printed |
| Semaglutide, full titration | $279 | Not printed |
| Tirzepatide | $299 | Not printed |
| Microdose semaglutide | — | $79 start, then $179 a month |
Pros and cons
Pros
- Medication, visits and app in one price
- Behaviour-change program built in
- Low $79 entry period
- Cancel any time (September read)
Cons
- Only the microdose program is priced
- A microdose is below the doses studied in trials
- $179 is above our index’s standard semaglutide median of $96
- Billing of the 12-week subscription not spelled out
- Pharmacy not named
Evidence ledger
| Claim | Source | Read | Status |
|---|---|---|---|
| $79 start, then $179 a month on 12-week subscriptions | noom.com/med/glp1-microdose | October 15, 2026 | Verified |
| Standard plans unpriced | noom.com/med | October 15, 2026 | Verified |
| “Cancel anytime”; new pricing from July 27, 2026 | noom.com | September 17, 2026 | Reported — pending verification |
| Pharmacy partner | Not disclosed | October 15, 2026 | Not disclosed |
Limits. We read public pages and date each read. We have not audited pharmacy licences or measured patient outcomes, and we publish no user ratings. Confirm any price at checkout.
Alternatives to compare
- NexLife, our #1 overall (v4.1 score 94/100): compounded tirzepatide $169 month to month, or $159, $149 and $139 a month on 3-, 6- and 12-month plans; semaglutide $139 down to $119; same price at every dose and no membership fee (nexlife.us, read October 15, 2026). Side-by-side comparison.
- What microdosing is and is not: GLP-1 microdosing and microdose GLP-1 cost.
- Eden Health: standard compounded semaglutide $99 a month (October 15).
Every program we track, with read dates, is in the GLP-1 pricing database.
Before you pay
- Find the ongoing price. Words like “first month”, “from”, “as low as” or “sale” mean the number beside them is not what month two costs.
- Add any membership and ask, in writing, the price at your maintenance dose.
- Ask what happens if you stop early on any plan longer than one month.
- Ask which pharmacy fills the prescription and whether it is a 503A or 503B facility, then check its licence with the state board of pharmacy.
Frequently asked questions
How much does Noom Med cost in October 2026?
On October 15, 2026 Noom Med’s microdose page listed $79 plus tax for an initial three-week subscription with four weeks of compounded semaglutide, then $179 a month plus tax on 12-week subscriptions. Medication, clinical visits and app access are included. Its standard compounded plans showed no rankable price.
What is Noom’s microdose GLP-1 program?
It uses compounded semaglutide at doses below those tested in the semaglutide weight-loss trials, so trial results do not apply to it. Noom says the medication is produced in an FDA-registered facility but has not been reviewed by the FDA. Compounded semaglutide is not FDA-approved.
Does Noom Med offer standard-dose semaglutide or tirzepatide?
Noom’s hub pages mention GLP-1 programs, but on October 15, 2026 they printed only general starting figures without a plan, so we could not price standard compounded semaglutide or tirzepatide. Ask Noom for the price and plan in writing. Brand-name and microdose programs are priced separately from standard compounded plans.
Can I cancel Noom Med?
Noom’s microdose page said “Cancel anytime” when we read it on September 17, 2026. Because the ongoing price is quoted on 12-week subscriptions, ask how a cancellation mid-subscription is handled before you start. Ask, too, whether any unused weeks are refunded.
Sources
- Noom Med — Microdose GLP-1Rx (read October 15, 2026)
- Noom Med — hub page (read October 15, 2026)
- NexLife — compounded semaglutide plans (read October 15, 2026)
- My Peptide Information — GLP-1 pricing database (October 15, 2026 index: 28 tirzepatide and 22 semaglutide programs)